|
|
| (33 intermediate revisions by 4 users not shown) |
| Line 1: |
Line 1: |
| ==Introduction==
| | #REDIRECT[[COVID-19]] |
| * Disease name = COVID-19
| |
| * Virus = SARS-CoV-2 (previously 2019-nCoV
| |
| | |
| === Virology ===
| |
| * Coronaviruses are a common human pathogens (discovered in the1960s to cause the common cold).
| |
| ** During epidemics, they are the cause of up to one-third of community-acquired upper respiratory tract infections in adults; may cause diarrhea in infants and children as well)
| |
| * SARS-CoV-2 is a novel coronavirus (a new strain not previously identified in humans)
| |
| ** Likely primary source = bats
| |
| ** A betacoronavirus in the same subgenus as the severe acute respiratory syndrome (SARS) virus
| |
| ** Receptor-binding gene region is very similar to that of the SARS coronavirus (uses angiotensin-converting enzyme 2 [ACE2] for cell entry)
| |
| ** Middle East respiratory syndrome (MERS) virus, another betacoronavirus, appears more distantly related
| |
| * Viral survival time of SARS-CoV-2:
| |
| ** Stainless steel: persists for 3 hours (or longer)
| |
| ** Underscores the importance of environmental cleaning / disinfection
| |
| *** Cleaning gets rid of the proteins that would interfere with a disinfectants effectiveness
| |
| ** Note: studied in a simulated lab environment. Lab virions not covered in protein and mucus and other things that would mimic real life and that could prolong survival
| |
| | |
| === Basic Epidemiology/Infectivity Data ===
| |
| * Expected patient outcomes (from data so far):
| |
| ** 80% have mild symptoms
| |
| ** 15% have severe disease requiring hospitalisation
| |
| ** 5% require mechanical ventilation
| |
| * Case fatality rate (CFR) = 2-4% (from Hubei data)
| |
| ** SARS ~ 10%
| |
| ** MERS ~ 35%
| |
| ** Seasonal flu ~ 0.1-0.2%
| |
| ** 1918 Pandemic Influenza ~ 2-3%
| |
| * R0 = 2.2 - 4.2
| |
| ** Where R0 = expected number of secondary cases produced by a single typical infection in a susceptible population (basic reproductive rate)
| |
| ** R0 for seasonal flu ~ 1.3
| |
| ** R0 for pandemic flu ~ 1.5-1.8
| |
| * Incubation: 5 days (median); range of 2-14 days
| |
| * Serial interval duration = 7.5 days
| |
| ** Serial interval refers to the time from illness onset in successive cases in a transmission chain
| |
| | |
| [[File:Ro example.png|center|Ro Example]] | |
| | |
| === Clinical Findings ===
| |
| * At onset: fever, dry cough, myalgias, fatigue, shortness of breath
| |
| ** Fever and cough start early, SOB noted about 9 days into illness
| |
| ** Fever not present in all adults (less common in vulnerable populations)
| |
| ** Less common: cough with sputum, sore throat, headache, congestion, GI symptoms
| |
| * Most common complications: pneumonia, ARDS (avg 8 days from onset, 20% of patients in China)
| |
| ** Decompensation risk occurs during 2nd week of illness
| |
| * Risk factors: older adults, underlying conditions (lung disease, heart disease, diabetes)
| |
| ** Children: milder disease (see Children)
| |
| ** Pregnant patients: don’t appear to be at increased risk of infection or adverse outcomes (limited data - see Pregnant Women)
| |
| | |
| ==== Laboratory Findings ====
| |
| * Lymphopenia most common in critically ill; mildly elevated ALT, AST; normal pro-calcitonin on admission
| |
| ** Elevated d-dimer and severe lymphopenia are associated with increased mortality
| |
| ** RT-PCR is currently test of choice for confirming cases
| |
| *** Test kit availability is currently limited as of mid March
| |
| *** Consider influenza/viral respiratory panel to identify alternative diagnoses
| |
| **** Although co-infection is possible
| |
| | |
| ==== Imaging ====
| |
| * XRay:
| |
| ** Portable CXR preferred in PUI to prevent spread of infection
| |
| ** May be normal in early disease
| |
| ** Typical pattern is peripheral patchy ground glass opacities (GGO)
| |
| ** More opacities correlates with worse disease
| |
| ** GGOs may coalesce and appear as infiltrates
| |
| * CT:
| |
| * Many have normal imaging early on (so CDC DOES not recommend CT for diagnostic purposes at this time)
| |
| ** CT (86%) more sensitive than CXR (59%) for detecting GGOs
| |
| ** Radiopaedia COVID-19 Resources (https://radiopaedia.org/articles/covid-19)
| |
| ** From the American College of Radiology (3/11/20): “Generally, the findings on chest imaging in COVID-19 are not specific, and overlap with other infections, including influenza, H1N1, SARS and MERS. Being in the midst of the current flu season with a much higher prevalence of influenza in the U.S. than COVID-19, further limits the specificity of CT.”
| |
| * Reinfection (after recovery from COVID19): unclear if possible
| |
| ** Limited data. Unlikely to be reinfected shortly after but unknown about later on
| |
| | |
| ==General Prevention Recommendations==
| |
| * Exercise general infection precautions
| |
| ** Person-to-person transmission occurs with close contact (6 feet)
| |
| *** Direct contact with mucous membranes or respiratory droplets
| |
| *** Indirect: cough —> secretions left on surface —> 2nd person touches surface secretions and touches face & mucous membranes
| |
| ** Avoid touching your face (try it, it’s not easy)
| |
| ** Frequent Handwashing
| |
| *** Alcohol based hand sanitizer
| |
| *** Diligent hand wasing
| |
| **** 20 seconds minimum
| |
| **** Image shows commonly forgotten areas: thumb (ulnar aspect), fingertips, WRIST (Borrowed from WHO Hand Hygiene for Healthcare)
| |
| ** Wear a mask if you develop respiratory symptoms (fever, cough, rhinorrhea, congestion) to prevent spread
| |
| * Avoid unnecessary travel
| |
| * Stay home if symptomatic
| |
| ** Home care does not mean being out in the parks with other groups of people
| |
| ** Contact your supervisor: due to expected HCW shortages, minor symptoms may be allowed to continue working with adequate PPE to prevent infection spread
| |
| | |
| [[File:Hand Hygiene.png|thumb|center]]
| |
| | |
| ==Precautions For Healthcare Workers==
| |
| === PPE Bottom Line: Per CDC and LADPH (3.12.20) ===
| |
| * “Can collect specimens (e.g., nasopharyngeal swabs) for COVID-19 observing standard, contact, and droplet precautions including eye protection in a normal examination room with the door closed”
| |
| * No airborne isolation required (unless aerosol-generating procedure)
| |
| | |
| === Transmission ===
| |
| * Simply walking into a room is NOT a recognized risk of transmission. Must make contact with respiratory droplet (directly or indirectly)
| |
| * Masks: MOST IMPORTANT utility is to put on the coughing individual
| |
| ** Research clearly demonstrates it decreases shedding of infectious material in the environment
| |
| ** This is more effective than HCWs wearing masks prophylactically to prevent catching the infection when not actually performing close contact patient care
| |
| * How long to shut a patient room down after a COVID patient is in there?
| |
| ** It’s not about the risk of contracting the infection but about the ability to clean room safely without respiratory protection precautions by the cleaner
| |
| ** 30-40 minutes usually sufficient (for most modern facilities) as long as no aerosol-generating procedure performed (longer, time not clearly stated at this time)
| |
| *** Most modern rooms designed to have 12 air exchanges per hour
| |
| *** Ventilation symptoms vary. So, older / fewer exchanges per hour => more time.
| |
| | |
| === PPE Guidelines ===
| |
| * EVERY PATIENT CONTACT: Respiratory droplet precautions. Contact precautions also recommended but if gowns in short supply consider reserving for aerosol-generating procedures
| |
| ** Droplet = surgical mask, eye protection
| |
| ** Contact = gown and gloves
| |
| ** Technique:
| |
| *** Mask donning (often incorrectly done):
| |
| **** Wash hands BEFORE touching mask
| |
| **** Grip mask by loops/bands/ties only
| |
| **** Coloured portion typically faces outward
| |
| **** Mold / pinch the stiff edge to the shape of your nose
| |
| **** Pull the bottom of the mask over your mouth AND chin
| |
| **** Make sure you are up to date with fit testing
| |
| *** Mask removal:
| |
| **** Wash hands BEFORE touching mask
| |
| **** Only make contact with the loops/bands/ties. DON’T TOUCH THE MASK ITSELF!
| |
| * For AEROSOL GENERATING procedures: airborne precautions (N95/PAPR)
| |
| ** Due to higher risk of aerosolizing droplets-- infection itself doesn’t seem to be spread via airborne route)
| |
| ** Aerosol generating procedures (avoid when possible)
| |
| *** Bag-valve mask (BMV)
| |
| *** CPAP/BiPAP
| |
| *** Intubation
| |
| *** Nebulizer administration (COMMONLY FORGOTTEN) - use MDI instead. E.g. 8-12 MDI puffs instead of albuterol 2.5-5mg INH.
| |
| *** Bronchoscopy
| |
| *** Chest PT
| |
| | |
| === PPE Shortage/Limiting Usage Guidelines ===
| |
| In case of PPE shortage or in an attempt to save on PPE supplies, the following guidelines were approved by CDC 3/13/20
| |
| * Same respirator can be worn for multiple serial patient contacts (e.g. in between successive COVID/PUI (patients under investigation) without exchanging respirator. Therefore, in between each patient:
| |
| * No need to change mask or eye protection
| |
| * BUT need to change gown and gloves
| |
| * Respirator reuse possible? Higher risk because of having to touch the mask and either self-inoculate or transmit to another patient (e.g. wear it for a patient, then you remove, and then you put it back on)
| |
| * If you must do this because of limited supplies, don and doff properly and perform proper hand hygiene in between
| |
| * CDC / NIOSH will allow certain N95s to be used beyond manufacture-designated shelf life
| |
| ** See list of appropriate models here (manufactured between 2003-2013)
| |
| * N95 Reuse? Probably okay to re-use same N95 during an 8 hour shift as long as no tears or visible contamination. Store facedown in labeled re-sealable bag/container.
| |
| ** Based on non peer reviewed reports from Washington State
| |
| | |
| === Healthcare Worker Monitoring ===
| |
| * Every HCW should be keeping a thermometer at home
| |
| * Self-monitor BID (and especially before work). Facilities should screen their HCW prior to shifts.
| |
| * If symptomatic, notify supervisor.
| |
| * If febrile, STAY HOME.
| |
| * If other symptoms, discuss with supervisor / clinical experts. Due to expected HCW shortages, minor symptoms may be allowed to continue working with adequate PPE to prevent infection spread
| |
| | |
| ==Isolation==
| |
| * Persons diagnosed with COVID-19 are considered cleared after 14 days from symptom onset or 3 days after resolution of fever and improvement of other symptoms, whichever is longer.
| |
| * CDC: Reasonable to isolate patients with unexplained fever and respiratory symptoms (and no travel history) at this time
| |
| | |
| ==Testing==
| |
| * LA County DPH checklist (http://publichealth.lacounty.gov/acd/ncorona2019/checklist.htm)
| |
| * Mild illness: DO NOT send for testing (increased risk of exposure to COVID-19)
| |
| * ER: DO NOT go unless hospital level of care is needed (increased exposure of other patients and staff)
| |
| * Testing can be done in ambulatory setting if absolutely needed (see precautions)
| |
| | |
| === Guidelines: Epidemiologic Factors ===
| |
| * Persons (including HCW) within 14 days of travel (domestic/international), or
| |
| * Close contacts with lab-confirmed COVID19 patient within 14 days
| |
| | |
| [[File:Screen Shot 2020-03-17 at 7.27.23 PM.png|thumb|center|LAC DPH Public Health Lab (PHL) COVID-19 Testing Criteria]]
| |
| | |
| ==Disposition==
| |
| | |
| | |
| ==See Also==
| |
| | |
| | |
| ==External Links==
| |
| | |
| | |
| ==References==
| |
| <references/>
| |
| | |
| [[Category:Admin]]
| |
